Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about European projects that are funded by European programmes including FP7, H2020, IMI, JNPD, AAL and EU Health. For projects funded under Horizon Europe, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

The neuroenergetics of memory consolidation – hybrid PET/MR imaging of the default mode network

SUGARCODING

Since its discovery more than a decade ago, the most studied network in the human brain remains a paradox. The default mode network (DMN) is most active during the resting state and deactivates once subjects engage in goal directed behavior. Although reported in hundreds of studies using functional magnetic resonance imaging (fMRI), the function of...

Funding Programme
Start Date
End Date
Total Funding
€ 1 499 404
European Countries Involved

The Next-Generation of Small, Cost-Effective and Mobile Brain Scanner for an Early Detection of Alzheimer’s Disease

BPET

Alzheimer’s (AD) is a global epidemic with 50 M people suffering it and 76 M expected by 2030 (related costs near $1 Tri in 2018). To diminish its burden, an early detection is crucial, specially when modifying treatments become available. The most accurate method to measure AD hallmarks is positron emission tomography (PET), but current PET...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

THE PRPC / PDK1 / TACE SIGNALING AXIS AT THE CROSS-ROAD OF SEVERAL AGGREGATE-PRONE PROTEIN-ASSOCIATED NEURODEGENERATIVE DISEASES

PrPC&PDK1

Neurodegenerative diseases such as Alzheimer's, Prion, Parkinson's diseases, Amyotrophic Lateral Sclerosis, Spino- cerebellar Ataxia and Fronto-temporal Dementia make up a group of pathologies with distinct etiologies and pathophysiological features characterized by the accumulation in the nervous system of abnormal proteins that are toxic for...

Funding Programme
Start Date
End Date
Total Funding
€ 1 461 047
European Countries Involved

The role of DREAM in synaptic dysfunction in Alzheimer's disease

DREAM IN AD

Alzheimer's disease (AD) is the most common form of age-related dementia. This neurodegenerative disorder is characterized by massive neuronal death and deposition of amyloid-β peptide (Aβ), which is formed by processing of amyloid precursor protein (APP). The mechanism of neuronal degeneration in AD are not well understood, but growing evidence...

Funding Programme
Start Date
End Date
Total Funding
€ 60 417
European Countries Involved

The role of immune cells in Alzheimer's disease

IMMUNOALZHEIMER

Alzheimer’s disease is the most common form of dementia affecting more than 35 million people worldwide and its prevalence is projected to nearly double every 20 years with tremendous social and economical impact on the society. There is no cure for Alzheimer's disease and current drugs only temporarily improve disease symptoms. Alzheimer's...

Funding Programme
Start Date
End Date
Total Funding
€ 2 500 000
European Countries Involved

The Role of Neuroinflammation in Alzheimer’s Disease

INFLAMM-ALZ

Alzheimer’s disease (AD) is a major public health problem with substantial economical and social impacts worldwide. Despite intense research, the pathological mechanisms of AD are still unclear. Under homeostasis, a delicate balance is struck between disposal of pathogenic proteins by the brain’s immune cells, microglia, and the inflammation...

Funding Programme
Start Date
End Date
Total Funding
€ 173 857
European Countries Involved

The Role of Non-coding RNA in Protein Networks and Neurodegenerative Diseases

RIBOMYLOME

'A major portion of the eukaryotic genome is occupied by DNA sequences whose transcripts do not code for proteins. This part of the genome is transcribed in a developmentally regulated manner and in response to external stimuli to produce large numbers of long non-coding RNAs (lncRNAs). From the beginning of transcription through splicing and...

Funding Programme
Start Date
End Date
Total Funding
€ 1 465 351
European Countries Involved

The role of the voltage-gated potassium channels and their modulators in mechanisms of plasticity underlying learning and memory in Drosophila

KV CHANNELS & MEMORY

Voltage-gated potassium (Kv) channel are neuronal and allow the temporal encoding of information as spike trains in neural circuits. It is therefore important to investigate how each Kv channel is able to do this so that we can better understand how brains work and generate plastic behaviour. In addition genetic diseases (channelopathies)...

Funding Programme
Start Date
End Date
Total Funding
€ 100 000
European Countries Involved

The structural and dynamical ensemble of an amyloidogenic intermediate

AMYLOIDINTERMEDIATE

Proteins and peptides have a generic tendency to convert from their soluble states into well-organized aggregates characterized by a fibrillar morphology and an extended cross-beta structure. Such transitions can give rise to over 40 pathological conditions ranging from neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease...

Funding Programme
Start Date
End Date
Total Funding
€ 171 868
European Countries Involved

The Unfolded Protein Response in Neurodegeneration

UPR NEURO

This proposal aims to increase our understanding of the role of translational failure in human neurodegenerative diseases. We recently discovered the mechanism by which protein misfolding leads to neurodegeneration in prion disease. The pathway involved is a generic cellular pathway, a branch of the unfolded protein response (UPR) that controls...

Funding Programme
Start Date
End Date
Total Funding
€ 1 979 286
European Countries Involved

The use of computational techniques to Improve compliance to reminders within smart environments

REMIND

The aim of this Project is to create an International and Intersectoral network to facilitate the exchange of staff to progress developments in reminding technologies for persons with dementia which can be deployed in smart environments. The focus will be on developing staff and partner skills in the areas of user centered design and behavioral...

Funding Programme
Start Date
End Date
Total Funding
€ 1 084 500
European Countries Involved

The zebrafish as a new vertebrate model for molecular and cellular mechanisms of learning and memory, including synaptic dysfunction in Alzheimer's disease

LEARNING AND MEMORY

A majority of our most common neurological diseases, such as Alzheimer’s disease, Parkinson’s disease, age-related dementia and multiple sclerosis, are manifested by memory loss and a reduced potential for learning. Additionally, a substantial portion of our population suffers from various forms of learning difficulties. Despite all the efforts to...

Funding Programme
Start Date
End Date
Total Funding
€ 231 852
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).